Primer: Jinxin Fertility (1951 HK) - Aug 2026
Jinxin Fertility is a leading Assisted Reproductive Services (ARS) provider with a strong presence in China and the U.S., but it is currently...
99 Views
APAC Healthcare Weekly (Mar 23)- Kissei, Alteogen, Junshi Biosciences, Celltrion, Lunit, HLB
​Kissei Pharma initiates additional P3 trial. Junshi Biosciences' drug got indication expansion. AstraZeneca partners with Alteogen. Celltrion aims...
635 Views
HK Connect Flows Weekly (Aug 28th): Alibaba, Smic, Hua Hong Semi, Akeso, Yofc, Cspc Pharma, Minimax
We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Alibaba, Smic, Hua Hong Semi, Akeso, Yofc, Cspc Pharma,...
95 Views
Smartkarma Originals
China Population Policies Impact on Healthcare Companies Series – Part 4
​Different provinces expand coverage for assisted reproductive services in medical insurance. Livzon missed expectation in 2023.US sanction on BGI...
2.6k Views
CX Daily: Frugality bites for China’s cash-strapped local governments
Local / In Depth: Frugality bites for China’s cash-strapped local governments Chinese local governments are gearing up for another tough year and...
375 Views